delolimogene mupadenorepvec
LOKON003
Phase 2 gene_therapy completed
Quick answer
delolimogene mupadenorepvec for Malignant Melanoma is a Phase 2 program (gene_therapy) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PRECISION BIOSCIENCES INC
- Indication
- Malignant Melanoma
- Phase
- Phase 2
- Modality
- gene_therapy
- Status
- completed